Literature DB >> 33617432

Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Children.

Alicia Caldwell1,2, Stephanie Moss3,4, Ashley Jenkins1,2, Brian Herbst1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33617432      PMCID： PMC7929610          DOI： 10.12788/jhm.3517

Source DB:  PubMed          Journal:  J Hosp Med        ISSN： 1553-5592            Impact factor:   2.960


× No keyword cloud information.
  11 in total

Review 1.  Management of thrombosis in children and neonates: practical use of anticoagulants in children.

Authors:  Paul Monagle; Fiona Newall
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Authors:  Maureane Hoffman; Joshua N Goldstein; Jerrold H Levy
Journal:  Int J Emerg Med       Date:  2018-12-03

3.  Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Mark Crowther; John W Eikelboom; C Michael Gibson; John T Curnutte; John H Lawrence; Patrick Yue; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Andrew M Demchuk; Daniel J Pallin; Mauricio Concha; Shelly Goodman; Janet Leeds; Sonia Souza; Deborah M Siegal; Elena Zotova; Brandi Meeks; Sadia Ahmad; Juliet Nakamya; Truman J Milling
Journal:  N Engl J Med       Date:  2019-02-07       Impact factor: 91.245

4.  Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Authors:  Christoph Male; Anthonie W A Lensing; Joseph S Palumbo; Riten Kumar; Ildar Nurmeev; Kerry Hege; Damien Bonnet; Philip Connor; Hélène L Hooimeijer; Marcela Torres; Anthony K C Chan; Gili Kenet; Susanne Holzhauer; Amparo Santamaría; Pascal Amedro; Elizabeth Chalmers; Paolo Simioni; Rukhmi V Bhat; Donald L Yee; Olga Lvova; Jan Beyer-Westendorf; Tina T Biss; Ida Martinelli; Paola Saracco; Marjolein Peters; Krisztián Kállay; Cynthia A Gauger; M Patricia Massicotte; Guy Young; Akos F Pap; Madhurima Majumder; William T Smith; Jürgen F Heubach; Scott D Berkowitz; Kirstin Thelen; Dagmar Kubitza; Mark Crowther; Martin H Prins; Paul Monagle
Journal:  Lancet Haematol       Date:  2019-11-05       Impact factor: 18.959

5.  Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.

Authors:  Charles V Pollack; Paul A Reilly; Joanne van Ryn; John W Eikelboom; Stephan Glund; Richard A Bernstein; Robert Dubiel; Menno V Huisman; Elaine M Hylek; Chak-Wah Kam; Pieter W Kamphuisen; Jörg Kreuzer; Jerrold H Levy; Gordon Royle; Frank W Sellke; Joachim Stangier; Thorsten Steiner; Peter Verhamme; Bushi Wang; Laura Young; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2017-07-11       Impact factor: 91.245

6.  American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.

Authors:  Paul Monagle; Carlos A Cuello; Caitlin Augustine; Mariana Bonduel; Leonardo R Brandão; Tammy Capman; Anthony K C Chan; Sheila Hanson; Christoph Male; Joerg Meerpohl; Fiona Newall; Sarah H O'Brien; Leslie Raffini; Heleen van Ommen; John Wiernikowski; Suzan Williams; Meha Bhatt; John J Riva; Yetiani Roldan; Nicole Schwab; Reem A Mustafa; Sara K Vesely
Journal:  Blood Adv       Date:  2018-11-27

Review 7.  Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.

Authors:  Antonio Gómez-Outes; Ana Isabel Terleira-Fernández; Ramón Lecumberri; M Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  Thromb Res       Date:  2014-07-06       Impact factor: 3.944

Review 8.  Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.

Authors:  K Martin; J Beyer-Westendorf; B L Davidson; M V Huisman; P M Sandset; S Moll
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824

9.  All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.

Authors:  Nicholas S Roetker; Pamela L Lutsey; Neil A Zakai; Alvaro Alonso; Terrence J Adam; Richard F MacLehose
Journal:  Thromb Haemost       Date:  2018-08-13       Impact factor: 5.249

10.  Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Authors:  Min Jun; Lisa M Lix; Madeleine Durand; Matt Dahl; J Michael Paterson; Colin R Dormuth; Pierre Ernst; Shenzhen Yao; Christel Renoux; Hala Tamim; Cynthia Wu; Salaheddin M Mahmud; Brenda R Hemmelgarn
Journal:  BMJ       Date:  2017-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.